Key result
Pulmonary thromboendarterectomy is described as the only curative treatment for chronic thromboembolic pulmonary hypertension, which otherwise leads to right heart failure and mortality.
This review provides an update on the role of echocardiography in the evaluation and management of chronic thromboembolic pulmonary hypertension.
May prompt echocardiography for early CTEPH detection to enable curative surgery; leaves open prospective validation of screening algorithms.
Copyright: © 2015 Marston N, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Chronic thromboembolic pulmonary hypertension (CTEPH) is the result of clot persistence and fibrosis in the pulmonary vasculature after acute pulmonary embolism. This condition leads to elevated pulmonary pressures and eventually right heart failure. Patients are often severely limited by exertional dyspnea and can experience significant morbidity and mortality when left untreated [1-3]. The condition is also associated with impairment of left ventricular diastolic function and filling. Pulmonary thromboendarterectomy (PTE) is currently the only curative treatment for CTEPH and greatly alters the clinical course of the disease.
No takes yet. Share an insight, caveat, or question.
Nicholas Marston Darrin Wong (2015) conducted a review in Chronic Thromboembolic Pulmonary Hypertension. Pulmonary thromboendarterectomy was evaluated. Pulmonary thromboendarterectomy is described as the only curative treatment for chronic thromboembolic pulmonary hypertension, which otherwise leads to right heart failure and mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: